Importance of the Genetic Diversity within the Mycobacterium tuberculosis Complex for the Development of Novel Antibiotics and Diagnostic Tests of Drug Resistance
Open Access
- 1 December 2012
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (12), 6080-6087
- https://doi.org/10.1128/aac.01641-12
Abstract
Despite being genetically monomorphic, the limited genetic diversity within the Mycobacterium tuberculosis complex (MTBC) has practical consequences for molecular methods for drug susceptibility testing and for the use of current antibiotics and those in clinical trials. It renders some representatives of MTBC intrinsically resistant against one or multiple antibiotics and affects the spectrum and consequences of resistance mutations selected for during treatment. Moreover, neutral or silent changes within genes responsible for drug resistance can cause false-positive results with hybridization-based assays, which have been recently introduced to replace slower phenotypic methods. We discuss the consequences of these findings and propose concrete steps to rigorously assess the genetic diversity of MTBC to support ongoing clinical trials.Keywords
This publication has 139 references indexed in Scilit:
- Mycobacterium tuberculosis – Heterogeneity revealed through whole genome sequencingTuberculosis, 2012
- Host–pathogen coevolution in human tuberculosisPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2012
- Insights from genomic comparisons of genetically monomorphic bacterial pathogensPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2012
- Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acidMicrobiology, 2012
- Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenasesChemico-Biological Interactions, 2011
- Implications of Isoniazid Resistance in Mycobacterium bovis Bacillus Calmette-Guerin used for Immunotherapy in Bladder CancerClinical Infectious Diseases, 2011
- Resolving lineage assignation on Mycobacterium tuberculosis clinical isolates classified by spoligotyping with a new high-throughput 3R SNPs based methodInfection, Genetics and Evolution, 2010
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconservedNature Genetics, 2010
- A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agentsJournal of Antimicrobial Chemotherapy, 2008
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998